GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $10,615,000 | +8.0% | 230,000 | 0.0% | 0.02% | +8.7% |
| Q4 2014 | $9,830,000 | -70.1% | 230,000 | -67.9% | 0.02% | -72.9% |
| Q3 2014 | $32,930,000 | -37.0% | 716,343 | -26.7% | 0.08% | -64.3% |
| Q2 2014 | $52,231,000 | -3.9% | 976,637 | -4.0% | 0.24% | -6.3% |
| Q1 2014 | $54,366,000 | +17.2% | 1,017,513 | +17.1% | 0.25% | +16.5% |
| Q4 2013 | $46,391,000 | +0.9% | 868,902 | -5.2% | 0.22% | -5.6% |
| Q3 2013 | $45,979,000 | +20.3% | 916,462 | +19.8% | 0.23% | +14.9% |
| Q2 2013 | $38,225,000 | – | 764,958 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |